2.Progress on preparation methods of animal model of deep venous thrombosis.
Lang JIN ; Bo LI ; Guang YANG
China Journal of Orthopaedics and Traumatology 2015;28(8):775-779
Deep venous thrombosis is a common and serious complication after orthopedics operation, with the characteristics of high incidence rate and death rate, its formation mechanism and the treatment is becoming more and more attention of scholars. Establishment of animal model of deep venous thrombosis can further explore the pathological process of thrombosis or dissolution, is an important means to research of thrombosis mechanism and evaluation of therapeutic method. This review discussed the basic principle of deep venous thrombosis, the selection of experimental animals and making method of animal models.
Animals
;
Disease Models, Animal
;
Venous Thrombosis
;
etiology
3.A case of acute carbon monoxide poisoning with secondary intestinal obstruction and thrombosis.
Cheng Jing YOU ; Zhi Jian ZHANG ; Li CHEN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2022;40(5):380-382
Acute carbon monoxide poisoning can cause multiple organ damage due to hypoxia. In severe cases, it can be life-threatening and has a high fatality rate. Intestinal obstruction and thrombosis are rare complications of carbon monoxide poisoning. A case of carbon monoxide poisoning was reported. In addition to the central nervous system lesion, intestinal obstruction and lower limb thrombosis were also found. In the treatment of carbon monoxide poisoning patients, the clinician was able to treat the common complications, attention should be paid to gastrointestinal tract, thrombotic disease and other rare complications, so as to avoid missed diagnosis.
Carbon Monoxide Poisoning/therapy*
;
Humans
;
Intestinal Obstruction/etiology*
;
Thrombosis/etiology*
5.Hereditary antithrombin deficiency and hyperhomocysteinemia in venous thromboembolic disease.
Zheng XI-XI ; Bing ZHONG-XING ; Liu BAO
Acta Academiae Medicinae Sinicae 2012;34(6):645-648
Hypercoagulability state is the result of the interplay of genetic predisposition and risk factors. Many key enzymes and reactions in coagulation and anti-coagulation system are involved. Hereditary antithrombin deficiency is one of the major risk factors of venous thromboembolic disease (VTE), whereas hyperhomocysteinemia may also play a role. This article reviews the recent researches on the contributions of these two factors to VTE.
Antithrombin III Deficiency
;
complications
;
Humans
;
Hyperhomocysteinemia
;
complications
;
Venous Thrombosis
;
etiology
7.Repeated sub-acute stent thrombosis: a case report.
Jing DAI ; Shuzheng LYU ; Xiantao SONG ; Hong LIU ; Rui TIAN ; Xin CHEN ; Changjiang GEI ; Yuan ZHOU ; Feng XU
Chinese Journal of Cardiology 2014;42(3):254-255
Aged
;
Humans
;
Male
;
Stents
;
adverse effects
;
Thrombosis
;
etiology
8.Internal jugular vein thrombosis with serious cervical necrotizing fasciitis: a case report.
Shujun CHEN ; Yuxuan CHEN ; Linwei ZHAO ; Chao CUI
West China Journal of Stomatology 2016;34(2):215-217
Cervical necrotizing fasciitis (CNF) is an aggressive infection associated with high mortality. Various complications have been described in previous literature. However, internal jugular vein thrombosis is rare in such lesions. We presented a case of internal jugular vein thrombosis caused by CNF and analyzed related literature.
Fasciitis, Necrotizing
;
complications
;
Humans
;
Jugular Veins
;
Neck
;
Venous Thrombosis
;
etiology
9.Complication analysis of intracranial aneurysm embolization with controllable coils.
Daming WANG ; Feng LING ; Anshun WANG
Chinese Medical Sciences Journal 2004;19(1):51-55
OBJECTIVETo explore the causes, prevention, and management of the complications during intracranial aneurysm embolization with controllable coils (mechanical detachable spiral, MDS; and Guglielmi detachable coil, GDC).
METHODSRetrospective review of 120 cases with 125 intracranial aneurysms embolized with controllable coils from March 1995 to July 1999 was conducted. The 20 accidents (in 18 cases) including aneurysm rupture, over-embolization, protrusion of coil end into the parent artery, and thrombosis of the parent artery were analyzed.
RESULTSAmong the 20 accidents, there were 6 aneurysm ruptures, 6 over-embolizations (in 5 cases), 6 coil protrusions, and 2 thromboses (one was secondary to coil protrusion). The embolization-related mortality was 3.33% (4/120), the permanent neurological deficit was 1.67% (2/120), and the transitory neurological deficit was 3.33% (4/120). The occurrence and outcome of the complications were related to the embolizing technique, the pattern of aneurysm and its parent artery, the imperfection of embolic materials, and the observation and management during embolization.
CONCLUSIONSkilled embolizing technique, better understanding of the angio-anatomy of an aneurysm and its parent artery, correct judgement and management during embolization, and improvement of embolic materials are beneficial to the reduction of complications and to the melioration of the outcome of complications.
Aneurysm, Ruptured ; etiology ; Embolization, Therapeutic ; adverse effects ; instrumentation ; Humans ; Intracranial Aneurysm ; therapy ; Retrospective Studies ; Thrombosis ; etiology
10.Pathogenesis and management of hemorrhage and thrombosis in plasma cell dyscrasias.
Journal of Experimental Hematology 2010;18(3):809-815
Unexpectedly high rates of venous thromboembolic events (VTE) induced by highly effective immune modulating drugs thalidomide and lenalidomide for treatment of multiple myeloma have focused attention on the incidence and underlying pathophysiology of VTE in patients with plasma cell dyscrasias, and on thromboprophylaxis approaches. While bleeding complications are relatively uncommon in the patients with lymphoproliferative disorders, acquired von Willebrand syndrome, typically occurring in the patients with monoclonal gammopathy of unknown significance, and acquired coagulopathies associated with primary amyloidosis can present with haemorrhagic complications and both are challenges to the management. This review highlights these important haemostasis-related complications of plasma cell dyscrasias and provides an overview of other uncommon bleeding and thrombotic events that can affect diagnosis and therapeutic management of clonal plasma cell disorders. Due to the infrequency of most these haemostasis complications, available information is typically based on retrospective cases or series analysis.
Hemorrhage
;
etiology
;
pathology
;
therapy
;
Humans
;
Paraproteinemias
;
complications
;
pathology
;
Thrombosis
;
etiology
;
pathology
;
prevention & control